ECRG4 and urinary bladder carcinoma: Rose et al. [56], for example, recently identified two promising DNA methylation biomarkers (ITIH5 and ECRG4) for non-invasive identification of bladder carcinomas, which have the potential to be used in conjunction with the Bladder EpiCheck test to achieve better performance.